Sortina Pharma appoints professor Hubert Hondermarck as scientific advisor

Professor Hondermarck is an internationally recognized leader in cancer biology and neuro-oncology, with a particular focus on the role of the nervous system in cancer progression. His pioneering work has helped define the emerging field of cancer neuroscience, highlighting how neural signaling and nerve–tumor interactions contribute to tumor growth, metastasis and treatment resistance.

He currently serves as Professor of Biomedical Science at the University of Newcastle, Australia, where he leads cutting-edge research into neurotrophins, tumor innervation and biomarkers for aggressive cancers, including brain and pancreatic cancer. His work has been widely published and internationally recognized for opening new therapeutic opportunities targeting tumor-nerve interactions.

Read more here


Previous
Previous

Sortina Pharma presents at Swedish Swiss Chamber of Commerce Life Science Event in Zurich

Next
Next

Sortina Pharma welcomes world-renowned neuro-oncologist professor Petra Hamerlik as scientific advisor